FindTrial
Sign In

The percutaneous kyphoplasty (PKP) in the treatment of osteoporotic vertebral burst fractures: a prospective study

The percutaneous kyphoplasty (PKP) in the treatment of osteoporotic vertebral burst fractures: a prospective study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042045
Enrollment
Unknown
Registered
2021-01-12
Start date
2021-01-11
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporotic vertebral burst fractures

Interventions

PKP group:PKP

Sponsors

Chao-Yang Hospital, China Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Patients with low back pain, and consistent with the site of vertebral burst fracture shown by MRI; B. CT confirmed vertebral burst fracture, vertebral compression range is less than 2 / 3 of the standard vertebral thickness, and the subjects have no neurological symptoms; C. VAS pain score is more than 6 points.

Exclusion criteria

Exclusion criteria: A. Patients who can not tolerate surgery; B. Patients with coagulation disorders; C. patients with bone cement allergy; D. patients with active infection.

Design outcomes

Primary

MeasureTime frame
VAS;ODI;Complications;radiological index;—

Countries

China

Contacts

Public ContactPeng Yin
yinpeng3904@126.com+86 18610306596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026